LADX
LadRx CorpCompany Information
- Company Name
- LadRx Corp
- CIK
- CIK0000799698
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- LADX: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- LADX
SEC filing data through
Insider Sentiment
- Last purchase
- 2013-12-10
- Last sale
- —
- Shares purchased (TTM)
- 459,633
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 1
- Shares outstanding
- 495,092
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2025-05-14
- Price on filing date
- —
- 1-month reaction
- 2.38%
- 3-month reaction
- -36.31%
Balance Sheet
Values in millions ($)| Line item | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 1 | 0 | 1 | 2 | 2 | 3 | 4 | 1 | 1 | 3 | 4 | ||||||
| Insurance Settlements Receivable Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | ||||||
| Assets Current | 0 | 1 | 0 | 1 | 2 | 2 | 3 | 4 | 1 | 2 | 3 | 5 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 1 | 0 | 1 | 2 | 2 | 3 | 4 | 1 | 2 | 3 | 5 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | ||||||
Stockholders Equity | ||||||||||||||||||
| Liabilities | - | - | - | - | - | 2 | 2 | - | - | 2 | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 489 | 489 | 489 | 489 | 489 | 489 | 489 | 489 | 488 | 488 | 487 | 487 | ||||||
| Retained Earnings Accumulated Deficit | -491 | -490 | -490 | -490 | -488 | -489 | -488 | -487 | -490 | -489 | -488 | -487 | ||||||
| Stockholders Equity | -2 | -1 | -2 | -1 | 0 | 0 | 1 | 2 | -2 | -1 | -0 | 1 | ||||||
| Liabilities And Stockholders Equity | 0 | 1 | 0 | 1 | 2 | 2 | 3 | 4 | 1 | 2 | 3 | 5 | ||||||
| Preferred Stock Dividend Rate Percentage | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | - | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | 62 | ||||||
| Common Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLadRx Corp (LADX) — SEC Financial Statements & Analysis
LadRx Corp (LADX) is a biological products, (no diagnostic substances) company, incorporated in DE. LadRx Corp trades on OTC as: LADX. LadRx Corp (LADX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-14. Based on that filing, LadRx Corp carries a market cap of $802.05K, a P/E ratio of -0.32x, a P/B ratio of -0.38x, an enterprise value of $595.10K, and an EV/EBITDA multiple of -0.17x. On profitability, it posts a Return on Equity (ROE) of 278.92% and a Return on Assets (ROA) of -201.16%. Per share, it reports EPS of $-5.04, diluted EPS of $-5.04, free cash flow per share of $-3.75, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -244.22% year-over-year and EPS growth of -244.22% year-over-year. On the balance sheet, it maintains a current ratio of 0.11x, a quick ratio of 0.09x, working capital of $-2.14M, a debt-to-equity ratio of -1.12x, a debt ratio of 9.21, free cash flow of $-1.86M (TTM), and net debt of $-206.95K. Figures sourced from SEC EDGAR.
- Market Cap
- $802.05K
- P/E TTM
- -0.32x
- EPS TTM
- $-5.04
- P/B TTM
- -0.38x
- ROE TTM
- 278.92%
- ROA TTM
- -201.16%
- Debt To Equity
- -1.12x
- Free Cash Flow TTM
- $-1.86M
Data as of 2025-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LadRx Corp in?
LadRx Corp (LADX) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does LADX trade on?
LadRx Corp (LADX) trades on the OTC.
Where is LadRx Corp incorporated?
LadRx Corp is incorporated in DE.
When was LadRx Corp (LADX)'s most recent SEC filing?
LadRx Corp (LADX)'s most recent SEC filing is a Form 10-Q for the period ended 2025-03-31, filed with the SEC on 2025-05-14.
What is LADX's market cap?
LadRx Corp (LADX) has a market capitalization of $802.05K as of 2025-03-31.
What is LADX's EPS (earnings per share)?
LadRx Corp (LADX)'s trailing twelve month EPS is $-5.04 as of 2025-03-31.
What is LADX's ROE (return on equity)?
LadRx Corp (LADX)'s trailing twelve month Return on Equity (ROE) is 278.92% as of 2025-03-31.
What is LADX's ROA (return on assets)?
LadRx Corp (LADX)'s trailing twelve month Return on Assets (ROA) is -201.16% as of 2025-03-31.
What is LADX's EV/EBITDA?
LadRx Corp (LADX)'s trailing twelve month EV/EBITDA is -0.17x as of 2025-03-31.

